INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

For the key trials, our articles and recipes, read the Atherosclerosis & Heart Disease desk →

1,829 studies · page 56 of 77

2017 / Crossover trial

Adding 30 g of insoluble dietary fiber to a high-fat high-calorie meal reduced postprandial inflammatory and ROS responses in normal fasting subjects.

Ten normal fasting subjects consumed a high-fat, high-calorie (HFHC) meal with or without 30 g of insoluble dietary fiber across two visits, with blood sampled over 5 hours. Adding fiber significantly lowered glucose excursion in the first 90 minutes and increased insulin and C-peptide secretion over the 5-hour period compared with the meal alone. The fiber addition prevented increases in lipopolysaccharide (LPS) and significantly reduced meal-induced increases in reactive oxygen species generation, as well as the expression of IL-1β, TNF-α, TLR-4, CD14, SOCS-3, and PTP-1B.

Ghanim H, Batra M, Abuaysheh S, et al. J Clin Endocrinol Metab, 2017. PMID 27906549

2017 / Randomized crossover trial

Adding freeze-dried strawberry powder to a high-fat meal did not alter postprandial vascular markers.

A randomized crossover trial in 30 overweight or obese adults assessed the impact of adding 40 g of freeze-dried strawberry powder to a high-fat meal. No significant differences appeared between the strawberry and control meals for any vascular or metabolic outcome. Both meals similarly reduced the augmentation index at 2 and 4 hours (P < 0.002) and increased postprandial triglycerides, insulin, and glucose relative to baseline (P < 0.001).

Richter CK, Skulas-Ray AC, Gaugler TL, et al. Am J Clin Nutr, 2017. PMID 28003205

2017 / Randomized, placebo-controlled, double-blind parallel trial

Resveratrol supplementation for 16 weeks did not improve metabolic syndrome markers and high doses increased total and LDL cholesterol.

A 16-week randomized, placebo-controlled, double-blind trial investigated daily oral supplementation with 1000 mg resveratrol (RSVhigh), 150 mg resveratrol, or placebo in 74 middle-aged men with metabolic syndrome. Resveratrol did not alter circulating hs-CRP, interleukin 6, soluble urokinase plasminogen activator receptor, or inflammatory gene expression in muscle and adipose tissues, and showed no effect on blood pressure, body composition, or glucose and lipid metabolism. However, RSVhigh treatment significantly increased total cholesterol (P < 0.002), LDL cholesterol (P < 0.006), and fructosamine (P < 0.013) compared with placebo.

Kjær TN, Ornstrup MJ, Poulsen MM, et al. J Clin Endocrinol Metab, 2017. PMID 28182820

2017 / Randomized controlled crossover trial

A fasting-mimicking diet reduced body fat, blood pressure, and disease risk factors.

In a randomized trial involving 100 healthy participants, three monthly 5-day cycles of a fasting-mimicking diet reduced body weight, trunk fat, total body fat, blood pressure, and insulin-like growth factor 1. Crossover of the control group resulted in 71 participants finishing three cycles without serious adverse effects. A post hoc analysis revealed that improvements in blood pressure, fasting glucose, cholesterol, triglycerides, and C-reactive protein were greater in individuals initially at risk for disease.

Wei M, Brandhorst S, Shelehchi M, et al. Sci Transl Med, 2017. PMID 28202779

2017 / Double-blind, parallel, randomized placebo-controlled trial

Encapsulated fruit and vegetable juice concentrate reduced total cholesterol, LDL cholesterol, and plasma TNFα, and increased lean mass in overweight/obese adults.

A double-blind, parallel, randomized placebo-controlled trial examined the effects of eight weeks of daily supplementation with six capsules of fruit and vegetable juice concentrate or placebo in 56 overweight and obese adults aged ≥40 years. Following consumption of the juice concentrate, total cholesterol, LDL cholesterol, and plasma TNFα decreased and total lean mass increased, with no change in the placebo group. In participants with high baseline systemic inflammation (serum CRP ≥3.0 mg/mL, n = 16), these effects were greater, though plasma CRP remained unchanged. The concentrate also altered the expression of genes involved in lipogenesis, NF-κB, and AMPK signalling pathways, such as PMVK, ZFAND5, and CAB39.

Williams EJ, Baines KJ, Berthon BS, et al. Nutrients, 2017. PMID 28208713

2017 / Randomized crossover trial

Virgin coconut oil increased total, LDL, and HDL cholesterol in postmenopausal women.

Twelve postmenopausal women consumed 30 mL daily of virgin coconut oil or safflower oil for 28 days in a crossover trial. Virgin coconut oil significantly elevated total cholesterol (+18.2 mg/dL), LDL cholesterol (+13.5 mg/dL), and HDL cholesterol (+6.6 mg/dL), while safflower oil did not alter lipids. Both oils produced neutral changes in total-to-HDL cholesterol ratios, and interleukin-1beta decreased in all participants with detectable samples after coconut oil.

Harris M, Hutchins A, Fryda L J Med Food, 2017. PMID 28277823

2017 / Pre-post intervention study

Consuming an energy beverage acutely attenuated arterial endothelial flow-mediated dilatation in young healthy adults.

Eleven young healthy medical students were tested at baseline and 90 minutes after consuming a 24-oz can of Monster Energy beverage. Heart rate and systolic/diastolic blood pressure did not change significantly from baseline. However, peak flow-mediated dilatation (FMD) was significantly attenuated after beverage consumption (baseline 5.9% ± 4.6% vs post-consumption 1.9% ± 2.1%; P = 0.03).

Higgins JP, Yang B, Herrin NE, et al. World J Cardiol, 2017. PMID 28289530

2017 / Randomized controlled trial

A whole food plant-based diet reduced BMI in adults with cardiometabolic risk factors.

In a randomized controlled trial of 65 adults with overweight or obesity and cardiometabolic conditions, an ad libitum whole food plant-based diet was compared to usual care. At 6 months, mean BMI reduction was significantly greater in the diet group (difference: 3.9 kg m-2, 95% CI ±1, P < 0.0001). Total cholesterol reduction did not significantly differ between groups unless dropouts were excluded (difference: 0.56 mmol l-1, P = 0.05).

Wright N, Wilson L, Smith M, et al. Nutr Diabetes, 2017. PMID 28319109

2017 / Randomized crossover trial

Circadian misalignment in chronic shift workers significantly increased 24-hour hs-CRP and blood pressure levels.

Chronic shift workers completed two 3-day laboratory protocols simulating night work (12-hour inverted cycles; circadian misalignment) or day work (circadian alignment) in a randomized crossover design. Circadian misalignment increased 24-h hs-CRP by 11% (p < 0.0001) and increased 24-h systolic blood pressure (SBP) by 1.4 mmHg and diastolic blood pressure (DBP) by 0.8 mmHg (both p ≤ 0.038). The increase in 24-h SBP was primarily driven by an increase during wakefulness (+1.7 mmHg; p = 0.017), while the increase in 24-h DBP was mainly during sleep opportunity (+1.8 mmHg; p = 0.005).

Morris CJ, Purvis TE, Mistretta J, et al. J Biol Rhythms, 2017. PMID 28347188

2017 / Randomized controlled crossover trial

Adding peanuts to a high-fat meal reduced postprandial triglycerides and maintained vascular function.

A randomized crossover study evaluated 15 healthy overweight or obese men who consumed high-fat shake meals containing either 85 g of ground peanuts or a matched control. Acute peanut intake blunted postprandial serum triglyceride levels at 120 minutes (188.9 ± 19.4 vs 197.5 ± 20.7 mg/dL) and 240 minutes (189.9 ± 24.3 vs 197.3 ± 18.4 mg/dL; both P < 0.05). Furthermore, flow-mediated dilatation decreased at 240 minutes after the control meal (-1.2% ± 0.5%, P = 0.029) but was preserved with peanuts.

Liu X, Hill AM, West SG, et al. J Nutr, 2017. PMID 28356431

2017 / Double-blind, parallel-design randomized clinical trial

Resveratrol supplementation did not consistently improve walking performance in older adults with peripheral artery disease.

The RESTORE trial randomized 66 patients aged 65 or older with peripheral artery disease to 125 mg/d resveratrol, 500 mg/d resveratrol, or placebo for 6 months. Six-month mean (SE) changes in 6-minute walk distance were 4.6 (8.1) m for the 125-mg group, -12.8 (7.5) m for the 500-mg group, and -12.3 (7.9) m for the placebo group (P = .07 for 125 mg vs placebo; P = .96 for 500 mg vs placebo). Changes in maximal treadmill walking time were 0.5 (2.3) minutes for 125 mg, -0.6 (2.1) minutes for 500 mg, and 0.4 (2.1) minutes for placebo (P = .18 and P = .12 vs placebo, respectively). The authors concluded there was no consistent evidence that resveratrol improves walking performance in this population.

McDermott MM, Leeuwenburgh C, Guralnik JM, et al. JAMA Cardiol, 2017. PMID 28403379

2017 / Randomized, double-blind crossover study

Acute theobromine intake did not alter postprandial apoA-I or lipid responses, while a high-fat meal reduced apoB48 and increased triacylglycerol.

Nine healthy men completed a randomized, double-blind crossover study comparing postprandial responses over 4 hours to a low-fat high-carbohydrate (LF) meal, a high-fat low-carbohydrate (HF) meal, and an LF meal with added theobromine. Postprandial apoA-I concentrations were comparable across all three meals. Compared to the LF meal, the HF meal led to significantly lower apolipoprotein B48 curves and significantly higher triacylglycerol curves, along with smaller decreases in free fatty acids and smaller increases in glucose and insulin. Theobromine did not alter postprandial responses to the LF meal, except for an increase in the incremental area under the curve for insulin.

Smolders L, Mensink RP, Plat J Nutr Res, 2017. PMID 28438412

2017 / Randomized crossover trial

Energy drinks prolonged QTc and increased systolic blood pressure more than caffeine alone.

In a randomized crossover trial of 18 healthy adults, participants drank 946 mL of an energy drink or a caffeine-matched control beverage. At 2 hours, the corrected QT interval change was significantly greater following the energy drink compared to caffeine alone (0.44±18.4 ms versus -10.4±14.8 ms; P=0.02). Systolic blood pressure was also higher at 6 hours post-consumption (4.72±4.67 mm Hg versus 0.83±6.09 mm Hg; P=0.01), with no differences observed in diastolic blood pressure or heart rate.

Fletcher EA, Lacey CS, Aaron M, et al. J Am Heart Assoc, 2017. PMID 28446495

2017 / Randomized clinical trial

Alternate-day fasting did not outperform daily calorie restriction for weight loss or cardioprotection.

In a 1-year randomized clinical trial of 100 obese adults, alternate-day fasting produced weight loss similar to daily calorie restriction at month 6 (-6.8% vs -6.8%) and month 12 (-6.0% vs -5.3%) relative to control. Blood pressure, heart rate, triglycerides, fasting glucose, and insulin resistance did not differ significantly between intervention groups. However, dropout was highest with alternate-day fasting (38%), and low-density lipoprotein cholesterol was significantly elevated at month 12 (11.5 mg/dL).

Trepanowski JF, Kroeger CM, Barnosky A, et al. JAMA Intern Med, 2017. PMID 28459931

2017 / Randomized controlled trial

Garlic supplementation improved brachial endothelial function in coronary artery disease patients.

Patients with coronary artery disease were randomized to receive garlic powder or dummy pills twice each day across a 3-month period. Ultrasound evaluation showed that flow-mediated dilation improved by 50.7% in the garlic group compared to the control group (p = 0.016). High-sensitivity C-reactive protein declined significantly with garlic but did not differ from control, and no alterations occurred in macrophage cholesterol efflux or mononuclear cell gene expression.

Mahdavi-Roshan M, Mirmiran P, Arjmand M, et al. Anatol J Cardiol, 2017. PMID 28554988

2017 / Controlled trial

Goji berry supplementation for 45 days reduced waist circumference, improved lipid profile, and enhanced antioxidant status in metabolic syndrome.

Patients with metabolic syndrome were assigned to a control group receiving healthy diet instructions or a supplemented group receiving healthy diet instructions plus 14 g of natural goji berry daily for 45 days. After 45 days, the supplemented group showed a significant reduction in transaminases and an improvement in lipid profile. Compared with the control group, the supplemented group had a significant reduction in waist circumference, along with increased glutathione and catalase levels associated with reduced lipid peroxidation.

de Souza Zanchet MZ, Nardi GM, de Oliveira Souza Bratti L, et al. Oxid Med Cell Longev, 2017. PMID 28685012

2017 / Randomized controlled trial

Blueberry smoothies reduced oxidative stress and modulated immune markers in metabolic syndrome.

Adults with metabolic syndrome were randomized to consume either freeze-dried blueberry smoothies or a placebo twice daily for six weeks. Blueberry supplementation reduced superoxide and total reactive oxygen species in monocytes and whole blood compared to placebo (p ≤ 0.05). It also raised myeloid dendritic cell counts, decreased monocyte expression of TNF-alpha, IL-6, and TLR4, and decreased circulating GMCSF levels (p ≤ 0.05).

Nair AR, Mariappan N, Stull AJ, et al. Food Funct, 2017. PMID 29019365

2017 / Multicenter, random-order, double-blind observational and interventional study

Enjoyment of spicy foods may significantly reduce individual salt preference, daily salt intake, and blood pressure by modifying central salty-taste processing.

In a multicenter, random-order, double-blind observational and interventional study, subjects with a high spice preference had a lower salt intake and blood pressure than subjects who disliked spicy food. Enjoyment of spicy flavor enhanced salt sensitivity and reduced salt preference, with salt intake and preference related to metabolic activity in the insula and orbitofrontal cortex (OFC). Capsaicin administration enhanced insula and OFC metabolic activity in response to high-salt stimuli, reversing salt intensity-dependent differences in metabolism.

Li Q, Cui Y, Jin R, et al. Hypertension, 2017. PMID 29089370

2017 / Randomized crossover trial

A mixed berry drink lowered cholesterol and improved working memory in older adults

Forty healthy older adults aged 50 to 70 consumed a mixed berry beverage or a matched control beverage daily for five weeks in a randomized crossover trial. The berry drink reduced total and LDL cholesterol compared to baseline (P < 0.05) and compared to control (P < 0.005 and P < 0.01). Working memory performance improved after the berry beverage compared to control (P < 0.05), but other cardiometabolic variables remained unchanged.

Nilsson A, Salo I, Plaza M, et al. PLoS One, 2017. PMID 29141041

2017 / Randomized, double-blind, placebo-controlled trial

Saffron aqueous extract and crocin reduced appetite, dietary intake, and body composition measures in patients with coronary artery disease.

In an 8-week randomized, double-blind, placebo-controlled trial, 84 patients with coronary artery disease were assigned to receive daily supplements of 30 mg saffron aqueous extract (SAE), 30 mg crocin, or placebo. Decreases in BMI, waist circumference, and fat mass were significantly greater in the SAE group than the crocin group (P < 0.001). Both SAE and crocin led to significant decreases in energy and dietary intake (P < 0.001 and P = 0.046, respectively) and appetite (P < 0.001 and P = 0.029, respectively), while placebo showed no change. No significant differences were observed in lipid profile parameters at the end of the study.

Abedimanesh N, Bathaie SZ, Abedimanesh S, et al. J Cardiovasc Thorac Res, 2017. PMID 29391933

2017 / Dose-response randomized, controlled, single-blind parallel trial

Consuming 50 g of quinoa daily for 12 weeks significantly reduced serum triglycerides and the prevalence of metabolic syndrome in overweight and obese adults.

A 12-week randomized controlled trial evaluated the effects of 25 g/d and 50 g/d of quinoa compared with a control group in 50 overweight and obese participants. Body composition, nutrient intake, and total, LDL, and HDL cholesterol were not significantly altered (P > 0.05). In the 50-g quinoa group, mean serum triglycerides dropped significantly from 1.14 to 0.72 mmol/L at 12 weeks (P < 0.05), and metabolic syndrome prevalence fell by 70%. In the 25-g group, metabolic syndrome prevalence decreased by 40% (from n = 7 at baseline to n = 4 at 12 weeks), with no significant triglyceride changes observed in the control or 25-g groups.

Navarro-Perez D, Radcliffe J, Tierney A, et al. Curr Dev Nutr, 2017. PMID 29955719

2016 / Randomized controlled trial

Eight weeks of Zumba improved fitness, body composition, and inflammatory markers in women.

In an eight-week randomized controlled study, 20 overweight and physically inactive women were allocated to either weekly Zumba fitness classes or habitual activity. Compared with controls, the Zumba group experienced a significant increase in maximal oxygen uptake of 3.1 mL·kg⁻¹·min⁻¹ and a 1.2% decrease in body fat percentage (p < 0.05). Interleukin-6 and white blood cell count also dropped significantly by 0.4 pg·mL⁻¹ and 2.1 × 10⁹ cells·L⁻¹, respectively (p < 0.01).

Domene PA, Moir HJ, Pummell E, et al. J Sports Sci, 2016. PMID 26571136

2016 / Randomized, double-blind, placebo-controlled parallel study

Six weeks of dietary nitrate from beetroot juice improved vascular function and reduced platelet-monocyte aggregates in hypercholesterolemic patients.

A randomized, double-blind, placebo-controlled study evaluated the effects of 6-week once-daily nitrate-rich beetroot juice versus nitrate-depleted beetroot juice in untreated hypercholesterolemic subjects. Dietary nitrate led to an absolute increase in flow-mediated dilatation of 1.1% (~24% improvement from baseline) compared to a 0.3% worsening with placebo (P < 0.001). Dietary nitrate also caused a 7.6% reduction in platelet-monocyte aggregates compared to a 10.1% increase with placebo (P = 0.004), reduced ex vivo stimulated P-selectin expression (P < 0.05), and altered the salivary microbiome, with no adverse effects detected.

Velmurugan S, Gan JM, Rathod KS, et al. Am J Clin Nutr, 2016. PMID 26607938

2016 / Randomized, double-blind, placebo-controlled trial

Taurine supplementation for 12 weeks significantly reduced blood pressure and improved vascular function in prehypertensive individuals.

A randomized, double-blind, placebo-controlled study assigned 120 prehypertensive individuals to receive 1.6 g per day of taurine or a placebo for 12 weeks. Taurine supplementation significantly decreased clinic systolic BP (mean reduction: 7.2 vs. 2.6 mm Hg for placebo) and diastolic BP (4.7 vs. 1.3 mm Hg), as well as ambulatory systolic BP (3.8 vs. 0.3 mm Hg) and diastolic BP (3.5 vs. 0.6 mm Hg). Supplementation also improved endothelium-dependent and endothelium-independent vasodilation and increased plasma H2S and taurine concentrations, which negatively correlated with BP changes.

Sun Q, Wang B, Li Y, et al. Hypertension, 2016. PMID 26781281